<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04667611</url>
  </required_header>
  <id_info>
    <org_study_id>1159007</org_study_id>
    <nct_id>NCT04667611</nct_id>
  </id_info>
  <brief_title>Patient-reported Outcome Measures (PROMs) in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study</brief_title>
  <acronym>SYMPA</acronym>
  <official_title>Patient-reported Outcome Measures (PROMs) as Characteristics and Prognostic Factors in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cohort study implements patient reported outcome measures (PROMs) for patients with&#xD;
      bodily stress syndrome in a clinic for functional disorders.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Sympa Cohort study is a prospective, single site cohort study that consists of&#xD;
      administration of PROMs questionnaires to patients that attend the Clinic for Functional&#xD;
      Disorders at Helsinki University hospital (HUS). The questionnaires are handed out to the&#xD;
      study population within seven days before their first visit at the clinic, and then at the&#xD;
      following 3, 6 and 12 months. The study population consists of consecutive adult patients&#xD;
      that are referred to the clinic either from other hospital units or primary care. The&#xD;
      collected data will later be linked with national registries on diagnoses, medication use and&#xD;
      work ability. The Sympa Cohort study may have implications in targeting the factors&#xD;
      influencing functional outcomes and quality of life reported by patients with bodily stress&#xD;
      syndrome. It will also form a quality register for the Clinic and characterize the first&#xD;
      systematic collection of PROMs related to these disorders in Finland.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self-rated global health improvement</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by clinical improvement scale (clinical global improvement, CGI), a five-point Likert scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional ability</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by WHODAS 2.0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PHQ-9</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GAD-7</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EUROHIS-QOL-8</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Health related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>15D</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Health related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SSD-12</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Symptom severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RS-14</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Resilience</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Fibromyalgia</condition>
  <condition>Irritable Bowel Syndrome</condition>
  <condition>Somatic Symptom</condition>
  <condition>Chronic Fatigue Syndrome</condition>
  <condition>Fatigue</condition>
  <condition>Dysphagia</condition>
  <condition>Exhaustion; Syndrome</condition>
  <arm_group>
    <arm_group_label>Mild</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychosocial interventions</intervention_name>
    <description>Cognitive behavioural therapy (CBT) based individual and group intervention</description>
    <arm_group_label>Mild</arm_group_label>
    <arm_group_label>Moderate</arm_group_label>
    <arm_group_label>Severe</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of consecutive patients referred to the Clinic for Functional&#xD;
        Disorders and who give their consent to be followed up during one year after their visit to&#xD;
        the clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All genders&#xD;
&#xD;
          -  Age 18-80 years&#xD;
&#xD;
          -  Referred to Clinic for Functional Disorders either from other hospital units or from&#xD;
             primary care&#xD;
&#xD;
          -  Willingness to be enrolled in the study, by signing the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not able to fill in the forms in Finnish or due to physical constraints (e.g.&#xD;
             dystonia)&#xD;
&#xD;
          -  Symptoms are likely due to a somatic disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helena Liira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helena Liira, MD, PhD</last_name>
    <phone>+358505771351</phone>
    <email>helena.liira@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jari Arokoski, MD, PhD</last_name>
    <phone>+358504287901</phone>
    <email>jari.arokoski@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for Functional Disorders, Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00009</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helena Liira, MD, PhD</last_name>
      <phone>+358 50 5771351</phone>
      <email>helena.liira@hus.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>December 8, 2020</last_update_submitted>
  <last_update_submitted_qc>December 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Helena Liira</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>bodily stress syndrome</keyword>
  <keyword>functional somatic symptoms</keyword>
  <keyword>functional somatic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Medically Unexplained Symptoms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

